The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines
Clinical trial NCT04391400 · UNKNOWN
Trial details
- NCT number
- NCT04391400
- Sponsor
- Invivoscribe, Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-06-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.